Valuation: Revvity, Inc.

Market Cap 17.03B 86.62B 15.14B 14.03B 12.77B 24.09B 1,617B 24.48B 169B 66.14B 844B 63.92B 62.56B 2,689B P/E 2026 *
64.3x
P/E 2027 * 50.6x
Enterprise Value 19.02B 96.71B 16.9B 15.67B 14.26B 26.9B 1,805B 27.33B 188B 73.84B 942B 71.37B 69.85B 3,003B EV / Sales 2026 *
6.67x
EV / Sales 2027 * 6.15x
Free-Float
99.74%
Yield 2026 *
0.19%
Yield 2027 * 0.18%
1 day+33.98%
Current month+33.98%
1 month+33.98%
3 months+38.00%
6 months+66.57%
Current year+47.59%
1 month 27.47
Extreme 27.47
27.75
Current year 14.91
Extreme 14.91
27.75
1 year 14.91
Extreme 14.91
27.75
3 years 14.51
Extreme 14.51
27.75
5 years 14.51
Extreme 14.51
39.55
10 years 11.96
Extreme 11.957142
39.55
Manager TitleAgeSince
Chief Executive Officer 61 29/12/2019
Director of Finance/CFO 37 05/09/2022
Chief Tech/Sci/R&D Officer - 30/04/2023
Director TitleAgeSince
Chairman 68 29/12/2019
Director/Board Member 74 06/02/2012
Director/Board Member 72 26/07/2016
Change 5-day change 1-year change 3-year change Capi.($)
+33.98%0.00% - - 17.03B
-1.21%+3.15%+25.60%+45.44% 255B
-1.50%+2.21%+8.49%+9.06% 161B
+0.94%+0.30%-6.44%+56.86% 151B
-0.08%+1.03%-55.94%-12.38% 64.33B
-1.65%+2.78%-15.79%-11.51% 51.9B
+1.47%+6.32%+10.02%+55.59% 50.25B
+0.60%+0.98%+15.87%+26.29% 49.92B
-0.67%+0.64%+20.58%+57.46% 48.77B
-0.47%+0.61%+26.68%+72.29% 42.93B
Average +3.11%+3.12%+3.23%+33.23% 97.22B
Weighted average by Cap. +0.11%+3.42%+6.81%+34.56%

Financials

2026 *2027 *
Net sales 2.85B 14.51B 2.54B 2.35B 2.14B 4.03B 271B 4.1B 28.25B 11.08B 141B 10.71B 10.48B 450B 3.01B 15.29B 2.67B 2.48B 2.25B 4.25B 285B 4.32B 29.79B 11.68B 149B 11.29B 11.05B 475B
Net income 274M 1.39B 243M 225M 205M 387M 25.97B 393M 2.71B 1.06B 13.55B 1.03B 1.01B 43.21B 346M 1.76B 308M 285M 260M 490M 32.86B 498M 3.43B 1.34B 17.15B 1.3B 1.27B 54.66B
Net Debt 1.99B 10.1B 1.76B 1.64B 1.49B 2.81B 188B 2.85B 19.66B 7.71B 98.32B 7.45B 7.29B 313B 1.46B 7.42B 1.3B 1.2B 1.09B 2.06B 138B 2.1B 14.44B 5.66B 72.22B 5.47B 5.36B 230B
Projected Income Statement - Annual - Revvity, Inc.
Logo Revvity, Inc.
Revvity, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales break down by family of products as follows: - medical diagnosis equipment (50.1%); - analytical tools and instruments (49.9%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales break down by source of revenue between sales of products (83.7%) and services (16.3%). Net sales are distributed geographically as follows: America (44%), Europe (28.9%) and Asia (27.1%).
Employees
11,000
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Revvity, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
152.64USD
Average target price
147.53USD
Spread / Average Target
-3.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Revvity, Inc.